1. Ajmal N., Lallas C.D., McCue P., Li L., Succinate dehydrogenase deficient renal cell carcinoma with sarcomatoid and rhabdoid features-a diagnostic dilemma. Int J Surg Pathol: 10668969241229333, 2024. PMID38311902.
2. Arai H., Yang Y., Baca Y., Millstein J., Denda T., Ou F.S., Innocenti F., Takeda H., Kubota Y., Doi A., Horie Y., Umemoto K., Izawa N., Wang J., Battaglin F., Jayachandran P., Algaze S., Soni S., Zhang W., Goldberg R.M., Hall M.J., Scott A.J., Hwang J.J., Lou E., Weinberg B.A., Marshall J., Goel S., Xiu J., Michael Korn W., Venook A.P., Sunakawa Y.,Lenz H.J., Predictive value of cdc37 gene expression for targeted therapy in metastatic colorectal cancer. Eur J Cancer. 201: 113914, 2024. PMID38359495.
3. Araya S., Chang A.H., Moss C., Gubara S.M., Gebreyesus M.T., Jordan K., Ruth K.J., Baltodano P., Patel S.A. Contemporary prophylactic antibiotic practices and adjunct therapies in autologous fat grafting procedures: A survey of the aesthetic society members. Aesthetic Surgery Journal Open Forum. 62024. WOS:001157816200001.
4. Bai Y., Zhang X., Li Y., Qi F., Liu C., Ai X., Tang M., Szeto C., Gao E., Hua X., Xie M., Wang X., Tian Y., Chen Y., Huang G., Zhang J., Xiao W., Zhang L., Liu X., Yang Q., Houser S.R., Chen X., Protein kinase a is a master regulator of physiological and pathological cardiac hypertrophy. Circ Res. 134(4): 393-410, 2024. PMID38275112.
5. Bartel M.J. Endoscopic resection of t1 colorectal cancer with unfavorable histologic features: What shall we do next? Gastrointest Endosc. 99(3): 417-418, 2024. PMID38368043.Editorial.
6. Beckermann K.E., Bestvina C.M., El Osta B., Sanborn R.E., Borghaei H., Lammers P.E., Selvaggi G., Whisenant J.G., Heimann-Nichols E., Berry L., Hsu C.Y., Shyr Y., Horn L., Wakelee H. A phase 1/2 study to evaluate the safety and activity of nivolumab in combination with vorolanib, a vascular endothelial growth factor tyrosine kinase inhibitor, in patients with refractory thoracic tumors. JTO Clin Res Rep. 5(2): 100619, 2024. PMID38328473.PMC10847019.
7. Begum T.F., Patil V.S., Zhu L., Yeh M.C., González E., Fraser M.A., Lu W.Y., Zhu S., Rubio-Torio N., Ma G.X., Tan Y. Assessing physicians’ recommendations for hepatitis b virus (hbv) and hepatitis c virus (hcv) testing among minority populations in greater Philadelphia and New York City. Journal of Community Health, 2024. WOS:001150463000001.
8. Bukavina L., Davis L., Helstrom E., Magee D., Ponsky L., Uzzo R., Calaway A., Abbosh P., Kutikov A., Population estimates of ovarian cancer risk in a cohort of patients with bladder cancer. Eur Urol Focus, 2024. PMID38326120.
9. Chen J., Bearz A., Kim D.W., Mamdani H., Bauman J., Chiari R., Ou S.I., Solomon B.J., Soo R.A., Felip E., Shaw A.T., Thurm H., Clancy J.S., Lee K., O’Gorman M., Tanski C., Pithavala Y.K., Evaluation of the effect of lorlatinib on cyp2b6, cyp2c9, ugt, and p-glycoprotein substrates in patients with advanced non-small cell lung cancer. Clin Pharmacokinet. 63(2): 171-182, 2024. PMID38079095.PMC10847213.
10. Chioccioli M., Liu S., Magruder S., Tata A., Borriello L., McDonough J.E., Konkimalla A., Kim S.H., Nouws J., Gonzalez D.G., Traub B., Ye X., Yang T., Entenberg D.R., Krishnaswamy S., Hendry C.E., Kaminski N., Tata P.R., Sauler M. Stem cell migration drives lung repair in living mice. Dev Cell, 2024. PMID38377991.
11. Clarke L.M., Jones R.M., Hiremath S.V., Franklin C., Wright W.G., Tucker C.A. The effects of age and height on gait smoothness in adolescent athletes. Children (Basel). 11(2)2024. PMID38397335.PMC10887815.
12. D’Avella C., Whooley P., Milano E., Egleston B., Helstrom J., Patrick K., Edelman M., Bauman J. The impact of an oncology urgent care center on healthcare utilization. JNCI Cancer Spectr, 2024. PMID38377387.
13. Dotan E., Lynch S.M., Ryan J.C., Mitchell E.P. Disparities in care of older adults of color with cancer: A narrative review. Cancer Medicine, 2024. WOS:001143858100001.
14. Emiloju O.E., Yin J., Koubek E., Reid J.M., Borad M.J., Lou Y., Seetharam M., Edelman M.J., Sausville E.A., Jiang Y., Kaseb A.O., Posey J.A., Davis S.L., Gores G.J., Roberts L.R., Takebe N., Schwartz G.K., Hendrickson A.E.W., Kaufmann S.H., Adjei A.A., Hubbard J.M., Costello B.A. Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs. 42(1): 127-135, 2024. PMID38270822.
15. Enke T., Keswani R., Triggs J., Gannavarapu B., Mittal C., Sinha J., Kwasny M.J., Komanduri S. Adherence to quality indicators and best practices in surveillance endoscopy of barrett’s esophagus: A video-based assessment. Endoscopy International Open. 12(01): E90-E96, 2024. WOS:001145872800006.
16. Fazliyeva R., Makhov P., Uzzo R.G., Kolenko V.M. Targeting npc1 in renal cell carcinoma. Cancers (Basel). 16(3)2024. PMID38339268.PMC10854724.
17. Gaines T., Simhan J. Adult hypospadias outcomes for the pediatric urologist. Curr Urol Rep, 2024. PMID38319558.
18. Gharzai L.A., Morris E., Suresh K., Nguyen-Tân P.F., Rosenthal D.I., Gillison M.L., Harari P.M., Garden A.S., Koyfman S., Caudell J.J., Jones C.U., Mitchell D.L., Krempl G., Ridge J.A., Gensheimer M.F., Bonner J.A., Filion E., Dunlap N.E., Stokes W.A., Le Q.T., Torres-Saavedra P., Mierzwa M., Schipper M.J. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: An individual patient data meta-analysis. Lancet Oncol. 25(3): 366-375, 2024. PMID38423050.
19. Harmange G., Hueros R.A.R., Schaff D.L., Emert B., Saint-Antoine M., Kim L.C., Niu Z.J., Nellore S., Fane M.E., Alicea G.M., Weeraratna A.T., Simon M.C., Singh A., Shaffer S.M., Disrupting cellular memory to overcome drug resistance. Nature Communications. 14(1)2023. WOS:001142811000001.
20. Heinrich M.C., Jones R.L., George S., Gelderblom H., Schöffski P., von Mehren M., Zalcberg J.R., Kang Y.K., Razak A.A., Trent J., Attia S., Le Cesne A., Siontis B.L., Goldstein D., Boye K., Sanchez C., Steeghs N., Rutkowski P., Druta M., Serrano C., Somaiah N., Chi P., Reichmann W., Sprott K., Achour H., Sherman M.L., Ruiz-Soto R., Blay J.Y.,Bauer S., Ripretinib versus sunitinib in gastrointestinal stromal tumor: Ctdna biomarker analysis of the phase 3 intrigue trial. Nat Med. 30(2): 498-506, 2024. PMID38182785.PMC10878977.
21. Henderson T.O., Allen M.A., Mim R., Egleston B., Fleisher L., Elkin E., Oeffinger K., Krull K., Ofidis D., McLeod B., Griffin H., Wood E., Cacioppo C., Weinberg M., Brown S., Howe S., McDonald A., Vukadinovich C., Alston S., Rinehart D., Armstrong G.T., Bradbury A.R. The engage study: A 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative pcp model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors. BMC Health Serv Res. 24(1): 253, 2024. PMID38414045.PMC10900774.
22. Hermida-Prado F., Xie Y.T., Sherman S., Nagy Z., Russo D., Akhshi T., Chu Z.T., Feit A., Campisi M., Chen M.Y., Nardone A., Guarducci C., Lim K., Font-Tello A., Lee I., García-Pedrero J., Cañadas I., Agudo J., Huang Y., Sella T., Jin Q.C., Tayob N., Mittendorf E.A., Tolaney S.M., Qiu X.T., Long H.Y., Symmans W.F., Lin J.R., Santagata S., Bedrosian I., Yardley D.A., Mayer I.A., Richardson E.T., Oliveira G., Wu C.J., Schuster E.F., Dowsett M., Welm A.L., Barbie D., Metzger O., Jeselsohn R. Endocrine therapy synergizes with smac mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer. Cancer Research. 83(19): 3284-3304, 2023. PMIDWOS:001083040500015.
23. Howell K.J., Jain A. Endometrial cancer treatment: Long-term engagement strategies. International Journal of Radiation Oncology Biology Physics. 118(2): 321-321, 2024. WOS:001164953000001. Editorial.
24. Isali I., Helstrom E.K., Uzzo N., Lakshmanan A., Nandwana D., Valentine H., Sindhani M., Abbosh P., Bukavina L. Current trends and challenges of microbiome research in bladder cancer. Curr Oncol Rep, 2024. PMID38376627.
25. Joshi K., Luisi B., Wunderlin G., Saleh S., Lilly A., Okusolubo T., Farabaugh P.J. An evolutionarily conserved phosphoserine-arginine salt bridge in the interface between ribosomal proteins us4 and us5 regulates translational accuracy in saccharomyces cerevisiae. Nucleic Acids Research, 2024. WOS:001160158300001.
26. Keating M., Ferrada P., O’Halloran P.J., Perry W., Potter S., Reddy S.S., Wilder F.G., Reynolds I.S., Tips for early career academic surgeons. Am J Surg, 2024. PMID38302367.
27. Kehm R.D., Knight J.A., Houghton L.C., McDonald J.A., Schwartz L.A., Goldberg M., Chung W.K., Frost C.J., Wei Y., Bradbury A.R., Keegan T.H.M., Daly M.B., Buys S.S., Andrulis I.L., John E.M., Terry M.B. Childhood physical activity and pubertal timing: Findings from the legacy girls study. Int J Epidemiol. 53(1)2024. PMID38205889.PMC10859159.
28. Khushman M.M., Toboni M.D., Xiu J., Manne U., Farrell A., Lou E., Shields A.F., Philip P.A., Salem M.E., Abraham J., Spetzler D., Marshall J., Jayachandran P., Hall M.J., Lenz H.J., Sahin I.H., Seeber A., Powell M.A. Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations. Clin Cancer Res, 2024. PMID38350001.
29. Kuter B.J., Brien K., Anderson S., Bass S.B., Gutierrez L., Winters S., Eichenlaub B., Whitfield C., Faig W. Covid-19 vaccine perspectives and uptake among university students three years into the pandemic. Vaccine, 2024. PMID38365478.
30. Lazim A., Mackrides N., Nasibli J., Pei J., Nejati R. ,Mansoor N. A t(14;18) negative nodal diffuse follicular lymphoma with 1p36/tnfrsf14 loh detected by cytogenomic microarray analysis. American Journal of Clinical Pathology. 160: S68-S68, 2023. WOS:001117683500001.
31. Luck C.C., Bass S.B., Chertock Y., Kelly P.J.A., Singley K., Hoadley A., Hall M.J. Understanding perceptions of tumor genomic profile testing in Black/African American cancer patients in a qualitative study: The role of medical mistrust, provider communication, and family support. J Community Genet, 2024. PMID38366313.
32. Mak K.S., Scannell Bryan M., Dignam J.J., Shipley W.U., Lin Y., Peters C.A., Gore E.M., Rosenthal S.A., Zeitzer K.L., D’Souza D.P., Horwitz E.M., Pisansky T.M., Maier J.M., Chafe S.M., Robin T.P., Roach M., 3rd, Tran P.T., Souhami L., Michalski J.M., Hartford A.C., Feng F.Y., Sandler H.M., Efstathiou J.A. Cardiovascular mortality and duration of androgen deprivation in locally advanced prostate cancer: Long-term update of nrg/rtog 9202. Eur Urol Focus, 2024. PMID38307806.
33. Masuda M.Y., Pyon G.C., Luo H., LeSuer W.E., Putikova A., Dao A., Ortiz D.R., Schulze A.R., Fritz N., Kobayashi T., Iijima K., Klein-Szanto A.J., Shimonosono M., Flashner S., Morimoto M., Pai R.K., Rank M.A., Nakagawa H., Kita H., Wright B.L., Doyle A.D. Epithelial overexpression of il-33 induces eosinophilic esophagitis dependent on il-13. J Allergy Clin Immunol, 2024. PMID38310974.
34. Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part i: Introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol: 101097ju0000000000003892, 2024. PMID38421253.
35. Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part iii: Salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions. J Urol: 101097ju0000000000003890, 2024. PMID38421252.
36. Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part ii: Treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol: 101097ju0000000000003891, 2024. PMID38421243.
37. Moulton N., Abbasi M., Ahmad D., Burks A., Chenna P., Haas K., Loiselle A., Mekhaiel E., Pilli S., Sadoughi A., Lydon B., Patel T., Chen A.C. Inter- and intra-observer variability of radial-endobronchial ultrasound image interpretation for peripheral pulmonary lesions. J Thorac Dis. 16(1): 450-456, 2024. PMID38410559.PMC10894385.
38. Mühlenberg T., Falkenhorst J., Schulz T., Fletcher B.S., Teuber A., Krzeciesa D., Klooster I., Lundberg M., Wilson L., Lategahn J., von Mehren M., Grunewald S., Tüns A.I., Wardelmann E., Sicklick J.K., Brahmi M., Serrano C., Schildhaus H.U., Sievers S., Treckmann J., Heinrich M.C., Raut C.P., Ou W.B., Marino-Enriquez A., George S., Rauh D., Fletcher J.A., Bauer S. Kit atp-binding pocket/activation loop mutations in gi stromal tumor: Emerging mechanisms of kinase inhibitor escape. J Clin Oncol: Jco2301197, 2024. PMID38408285.
39. Muir A.B., Karakasheva T., Whelan K.A. Epithelial-fibroblast crosstalk in eosinophilic esophagitis. Cell Mol Gastroenterol Hepatol, 2024. PMID38316214.
40. Nakata J.A., Arif A., Chai L.F., Su S. First report of a post-pneumonectomy nocardia empyema. J Surg Case Rep. 2024(1): rjae002, 2024. PMID38304314.PMC10832585.
41. Naqash A.R., Floudas C.S., Aber E., Maoz A., Nassar A.H., Adib E., Choucair K., Xiu J., Baca Y., Ricciuti B., Alessi J.V., Awad M.M., Kim C., Judd J., Raez L.E., Lopes G., Nieva J.J., Borghaei H., Takebe N., Ma P.C., Halmos B., Kwiatkowski D.J., Liu S.V. ,Mamdani H. Influence of tp53 comutation on the tumor immune microenvironment and clinical outcomes with immune checkpoint inhibitors in stk11-mutant non-small-cell lung cancer. JCO Precis Oncol. 8: e2300371, 2024. PMID38330261.PMC10860998.
42. Neelapu S.S., Chavez J.C., Sehgal A.R., Epperla N., Ulrickson M., Bachy E., Munshi P.N., Casulo C., Maloney D.G., de Vos S., Reshef R., Leslie L.A., Oluwole O.O., Yakoub-Agha I., Khanal R., Rosenblatt J., Korn R., Peng W., Lui C., Wulff J., Shen R., Poddar S., Jung A.S., Miao H., Beygi S., Jacobson C.A. Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-hodgkin lymphoma (zuma-5). Blood. 143(6): 496-506, 2024. PMID37879047.
43. Parham L.R., Williams P.A., Katada K., Nettleford S.K., Chatterji P., Acheampong K.K., Danan C.H., Ma X., Simon L.A., Naughton K.E., Mizuno R., Karakasheva T., McMillan E.A., Whelan K.A., Brady D.C., Shaffer S.M., Hamilton K.E. Igf2bp1/imp1 deletion enhances a facultative stem cell state via regulation of map1lc3b. Cell Mol Gastroenterol Hepatol. 17(3): 439-451, 2024. PMID38081361.PMC10835461.
44. Parker C.S., Zhou L.L., Prabhu V.V., Lee S., Miner T.J., Ross E.A., El-Deiry W.S. Onc201/tic10 plus tly012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor dr5 in gastric adenocarcinoma. American Journal of Cancer Research. 13(12): 6290-6312, 2023. WOS:001143926000003.
45. Poloyac S.M., Daugherty K.K., DeVilliers M.M., Farrell D.F., Malhotra A., Nolin T.D., Panyam J., Perumal O., Sheaffer E.A., Swaan P.W. Report of the 2023 aacp council of deans taskforce on pharmacy research and scholarship. Am J Pharm Educ. 88(2): 100641, 2024. PMID38185465.
46. Preston K.J., Kawai T., Torimoto K., Kuroda R., Nakayama Y., Akiyama T., Kimura Y., Scalia R., Autieri M.V., Rizzo V., Hashimoto T., Osei-Owusu P., Eguchi S. Mitochondrial fission inhibition protects against hypertension induced by angiotensin ii. Hypertens Res, 2024. PMID38383894.
47. Reese J.B., Bauman J.R., Sorice K.A., Frederick N., Bober S.L., Hematology and oncology fellow education about sexual and reproductive health: A survey of program directors in the united states. JCO Oncol Pract: Op2300499, 2024. PMID38320223.
48. Saaoud F., Lu Y., Xu K., Shao Y., Praticò D., Vazquez-Padron R.I., Wang H., Yang X., Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers – targeting perk as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer. Pharmacol Ther. 255: 108604, 2024. PMID38360205.
49. Sasaki M., Hara T., Wang J.X., Zhou Y., Kennedy K.V., Umeweni N.N., Alston M.A., Spergel Z.C., Ishikawa S., Teranishi R., Nakagawa R., McMillan E.A., Whelan K.A., Karakasheva T.A., Hamilton K.E., Ruffner M.A., Muir A.B. Lysyl oxidase regulates epithelial differentiation and barrier integrity in eosinophilic esophagitis. Cell Mol Gastroenterol Hepatol, 2024. PMID38340809.
50. Sherry D.R., Patell R., Han H.J., Dodge L.E., Braun I.M., Buss M.K., Palliative medicine fellows’ discussions, perceptions, and training regarding medical cannabis. J Pain Symptom Manage, 2024. PMID38417464.
51. Simons M., Sharaiha R.Z., Updates in metabolic bariatric endoscopy. Dig Endosc. 36(2): 107-115, 2024. PMID37405807.
52. Sterling J., Simhan J., Flynn B.J., Rusilko P., França W.A., Ramirez E.A., Angulo J.C., Martins F.E., Patel H.V., Higgins M., Swerdloff D., Nikolavsky D., Reply by authors. J Urol: 101097ju0000000000003888, 2024. PMID38382012.
53. Strother M., Barlotta R., Uzzo R., Bloom E., Jazayeri S.B., Bigalli A.C., Schober J., Lee J., Bernstein A., Ginsburg K., Handorf E., Chen D.Y., Correa A., Greenberg R., Smaldone M., Viterbo R., Kutikov A. Symptomatic and functional recovery after transurethral resection of bladder tumor: Data from ecological momentary symptom assessment. Urol Oncol, 2024. PMID38369443.
54. Sun J., Karasaki K.M., Farma J.M. The use of gene expression profiling and biomarkers in melanoma diagnosis and predicting recurrence: Implications for surveillance and treatment. Cancers (Basel). 16(3)2024. PMID38339333.PMC10854922.
55. Sun Y., Young M.C., Woodward C.H., Danon J.N., Truong H., Gupta S., Winters T.J., Font-Burgada J., Burslem G.M., Sgourakis N.G. Universal open mhc-i molecules for rapid peptide loading and enhanced complex stability across hla allotypes. Proceedings of the National Academy of Sciences of the United States of America. 120(25)2023. WOS:001041283500001.
56. Topchu I., Bychkov I., Gursel D., Makhov P., Boumber Y. Nsd1 supports cell growth and regulates autophagy in hpv-negative head and neck squamous cell carcinoma. Cell Death Discov. 10(1): 75, 2024. PMID38346948.PMC10861597.
57. Torres-Ayuso P., Katerji M., Mehlich D., Lookingbill S.A., Sabbasani V.R., Liou H., Casillas A.L., Chauhan S.S., Serwa R., Rubin M.R., Marusiak A.A., Swenson R.E., Warfel N.A., Brognard J. Pim1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell Chem Biol. 31(2): 326-337.e11, 2024. PMID38016478.
58. Trujillo M.N., Jennings E.Q., Hoffman E.A., Zhang H., Phoebe A.M., Mastin G.E., Kitamura N., Reisz J.A., Megill E., Kantner D., Marcinkiewicz M.M., Twardy S.M., Lebario F., Chapman E., McCullough R.L., D’Alessandro A., Snyder N.W., Cusanovich D.A., Galligan J.J. Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation. Mol Metab. 81: 101888, 2024. PMID38307385.PMC10869261.
59. Uboveja A., Huang Z., Buj R., Amalric A., Wang H., Tangudu N.K., Cole A.R., Megill E., Kantner D., Chatoff A., Ahmad H., Marcinkiewicz M.M., Disharoon J.A., Graff S., Dahl E.S., Hempel N., Stallaert W., Sidoli S., Bitler B.G., Long D.T., Snyder N.W., Aird K.M. Αkg-mediated carnitine synthesis promotes homologous recombination via histone acetylation. bioRxiv, 2024. PMID38370789.PMC10871207 (Pre-Print).
60. Wang Y., He S., Calendo G., Bui T., Tian Y.Y., Lee C.Y., Zhou Y., Zhao X., Abraham C., Mo W.B., Chen M.M., Sanders-Braggs R., Madzo J., Issa J.P., Hexner E.O., Wiest D.L., Reshef R., Xue H.H., Zhang Y. Tissue-infiltrating alloreactive t cells require id3 to deflect pd-1-mediated immune suppression during gvhd. Blood. 143(2): 166-177, 2024. WOS:001155837900001.
61. Wei S., Krause H.B., Geynisman D.M., Elliott A., Kutikov A., Uzzo R.G., Pei J., Barata P., Carneiro B., Heath E., Ryan C., Farrell A., Nabhan C., Ali-Fehmi R., Naqash A.R., Argani P.,McKay R.R., Molecular characterization of tfe3-rearranged renal cell carcinoma: A comparative study with papillary and clear cell renal cell carcinomas. Mod Pathol. 37(2): 100404, 2024. PMID38104891.
62. Yang Y., Liu L., Tian Y., Gu M., Wang Y., Ashrafizadeh M., Reza Aref A., Cañadas I., Klionsky D.J., Goel A., Reiter R.J., Wang Y., Tambuwala M.,Zou J., Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics. Cancer Lett. 587: 216659, 2024. PMID38367897.
63. Yong V., Rostmeyer K., Erkmen C.P. Reply from authors: Reading between the lines: Guidance for applicants and authors of letters of recommendation. J Thorac Cardiovasc Surg. 167(3): e61-e62, 2024. PMID37768259.
64. Zabransky D.J., Chhabra Y., Fane M.E., Kartalia E., Leatherman J.M., Hüser L., Zimmerman J.W., Delitto D., Han S., Armstrong T.D., Charmsaz S., Guinn S., Pramod S., Thompson E.D., Hughes S.J., O’Connell J., Egan J.M., Jaffee E.M., Weeraratna A.T. Fibroblasts in the aged pancreas drive pancreatic cancer progression. Cancer Res, 2024. PMID38330147.
talbotresearchlibrary.wordpress.com 